Combination Therapy With Dalfampridine and Locomotor Training for Chronic, Motor Incomplete Spinal Cord Injury

NCT01621113 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Spinal Cord Injury

Interventions

DRUG: Dalfampridine
DRUG: Placebo

Sponsor

Kessler Foundation

Collaborators

[object Object]
[object Object]